Moors & Cabot’s Amgen AMGN Stock Holding History

Moors & Cabot’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,100	Closed	-$1K	–	671
2019 Q2	$1K	Hold	1,100	–	–	﹤0.01%	553
2019 Q1	$1K	Buy	+1,100	New	+$210K	﹤0.01%	527
2016 Q3	–	Sell	-1,100	Closed	-$2K	–	550
2016 Q2	$2K	Buy	+1,100	New	+$171K	﹤0.01%	517
2016 Q1	–	Sell	-1,100	Closed	-$2K	–	524
2015 Q4	$2K	Buy	+1,100	New	+$173K	﹤0.01%	514

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Moors & Cabot's AMGN Position: Q3 2026 in Review

Moors & Cabot increased its Amgen (AMGN) stake by 24% in Q3 2026, buying an estimated $1.39M and bringing the position to 18,382 shares worth $7.75M. The position accounts for 0.29% of the portfolio, ranked #64.

Moors & Cabot first reported a position in AMGN in Q1 2014 and has held it in 51 quarters since. 2,162 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Moors & Cabot held 18,382 shares of Amgen worth $7.75M as of Q3 2026.
Moors & Cabot bought 3,498 Amgen shares in Q3 2026, an estimated $1.39M.
Amgen made up 0.29% of Moors & Cabot's portfolio in Q3 2026, its #64 holding.
Moors & Cabot first reported a position in Amgen in Q1 2014 and has held it in 51 quarters since.
2,162 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.